Author(s):
Nebita Maria Jarrett, Gloria Jemmi Christobel R., Abirami M.P., Shyam Sundar J., Radhakrishnan S., Deepa S., Abirami S., Shila S.
Email(s):
shilasamuel72@gmail.com
DOI:
10.5958/0974-360X.2020.00716.7 
Address:
Nebita Maria Jarrett, Gloria Jemmi Christobel R., Abirami M.P., Shyam Sundar J., Radhakrishnan S., Deepa S., Abirami S., Shila S.*
Department of Biochemistry, VRR Institute of Biomedical Science, (Affiliated to University of Madras) Chennai, Tamilnadu, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 9,
Year - 2020
ABSTRACT:
Ovarian cancer is one of the leading deadliest cancers among women and new therapeutic options with lesser side effects are in urgent need. Naringin is a citrus flavonoid recently studied for anti-cancer activity in numerous cancer cells. Evasion of apoptosis is the hallmark of cancer and therefore we investigated the potential of naringin to induce anti-proliferative and apoptotic effects in PA-1 ovarian cancer cells. Trypan blue assay and Western blotting techniques were employed on the treated and untreated PA-1 cells for anti-proliferative and apoptosis analysis. Naringin effectively reduced viability of PA-1 cell line. Immunoblot analysis revealed marked changes in the upregulation of pro-apoptotic markers like Bax and Caspase-3 along with downregulation of anti-apoptotic marker Bcl-2. Taken together, our results suggest that treating naringin may offer a new therapeutic strategy to improve the survival rates of ovarian cancer patients.
Cite this article:
Nebita Maria Jarrett, Gloria Jemmi Christobel R., Abirami M.P., Shyam Sundar J., Radhakrishnan S., Deepa S., Abirami S., Shila S. Cytotoxic and Apoptotic Effect of Citrus Flavonoid Naringin in Treating PA-1 Ovarian Cancer Cells. Research J. Pharm. and Tech 2020; 13(9):4051-4054. doi: 10.5958/0974-360X.2020.00716.7
Cite(Electronic):
Nebita Maria Jarrett, Gloria Jemmi Christobel R., Abirami M.P., Shyam Sundar J., Radhakrishnan S., Deepa S., Abirami S., Shila S. Cytotoxic and Apoptotic Effect of Citrus Flavonoid Naringin in Treating PA-1 Ovarian Cancer Cells. Research J. Pharm. and Tech 2020; 13(9):4051-4054. doi: 10.5958/0974-360X.2020.00716.7 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-9-4
REFERENCES:
1. Siegel RL, Miller KD and Jemal A. Cancer statistics. CA Cancer J. Clin. 2016: 66; 7–30.
2. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N and Sessa C. ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2013: 24(suppl_6); 24-32.
3. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL and Rowland JH. Cancer treatment and survivorship statistics. CA Cancer J. Clin. 2016: 66; 271–289.
4. Pignata S, Scambia G, Ferrandina G, Savarese A, Sorio R and Breda E. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2011: 29; 3628–3635.
5. Gol M, Saygili U, Koyuncuoglu M and Uslu T. Influence of high-dose methotrexate therapy on the primordial follicles of the mouse ovary. The journal of obstetrics and gynaecology research. 2009: 35; 429-433.
6. Bondre AV, Akare SC, Mourya P, Wanjari AD, Tarte PS, and Paunikar GV. In Vitro Cytotoxic Activity of Leaves of Abutilon indicum Linn. Against Ehrlich Ascites Carcinoma and Dalton’s Ascitic Lymphoma Cell Line. Research J. Pharmacognosy and Phytochemistry. 2009: 1(1); 72-74.
7. Kumar S, Pathania AS, Saxena AK, Vishwakarma RA, Ali A and Bhunshan S. The anticancer potential of flavonoids isolated from the stem bark of Erythrinasuberosa through induction of apoptosis and inhibition of STAT signalling pathway in human leukaemia HL-60 cells. Chemico-Biological Interactions. 2013: 205; 128–137.
8. Aroui S, Aouey B, Chtourou Y, Meunier AC, Fetoui H and Kenani A. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Chemico-biological interactions. 2016 Jan 25: 244; 195-203.
9. Aroui S, Najlaoui F, Chtourou Y, Meunier AC, Laajimi A, Kenani A, Fetoui H. Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway. Tumor Biology. 2016 Mar 1: 37(3); 3831-9.
10. Guo B, Zhang Y, Hui Q, Wang H, Tao K. Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src. Tumor Biology. 2016 Mar 1: 37(3); 3841-50.
11. Kim DI, Lee SJ, Lee SB, Park K, Kim WJ and Moon SK. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis 2008: 29; 1701-1709.
12. Li H, Yang B, Huang J, Xiang T, Yin X, Wan J, Luo F, Zhang L, Li H and Ren G. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicol Lett 2013: 220; 219-228.
13. Zeng L, Zhen Y, Chen Y, Zou L, Zhang Y, Hu F, Feng J, Shen J and Wei B: Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF-κB/COX 2 caspase-1 pathway in HeLa cervical cancer cells. Int J Oncol 2014: 45; 1929-1936.
14. Srivalli Tripuramallu, Srikanth Sunkara, Venkata Ramana Reddy and Maram Cytotoxic Activity of Glocihdium zeylanicum Leaf Extract. Research J. Pharmacology and Pharmacodynamics. 2009: 1(3); 145-146.
15. Poonam Gupta, Mohd. Yaqub Khan, Vikas Kumar Verma, Ashish Pathak. Beating cancer with natural plant sources. Asian journal of Pharmacy and Technology. 2013: 3(2); 39-44.
16. Kaur M, Badhan RK. Phytoestrogens modulate breast cancer resistance protein expression and function at the blood-cerebrospinal fluid barrier. Journal of Pharmacy & Pharmaceutical Sciences. 2015 May 6;18(2):132-54
17. Vadde R, Radhakrishnan S, Reddivari L and Vanamala JK. Triphala extract suppresses proliferation and induces apoptosis in human colon cancer stem cells via suppressing c-Myc/cyclin D1 and elevation of Bax/Bcl-2 ratio. BioMed research international. 2015.
18. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. cell. 2011 Mar 4: 144(5); 646-74.
19. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, and Bahar I. Bistability in apoptosis: roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophys J. 2006: 90(5); 1546–1559.
20. Cory S and Adams JM. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell. 2005; 8(1): 5–6.
21. Ramesh E and Alshatwi AA. Naringin induces death receptor and mitochondria- mediated apoptosis in human cervical cancer (SiHa) cells. Food ChemToxicol. 2013: 51; 97–105.
22. Banjerdpongchai R, Wudtiwai B and Khawon P. Induction of human hepatocellular carcinoma HepG2 cell apoptosis by naringin. Asian Pac J Cancer Prev. 2016: 17 (7) ; 3289-3294.